Carrier Proteins - Lymphocyte Antigen 96 PubMed MeSh Term

Overview

subject area of

• A Peptide Antagonist of the TLR4-MD2 Interaction  Journal Article
• An MD2 Hot-Spot-Mimicking Peptide that Suppresses TLR4-Mediated Inflammatory Response in vitro and in vivo  Journal Article
• Application of a novel in silico high-throughput screen to identify selective inhibitors for protein-protein interactions  Journal Article
• EVIDENCE THAT INTRATHECAL MORPHINE-3-GLUCURONIDE MAY CAUSE PAIN ENHANCEMENT VIA TOLL-LIKE RECEPTOR 4/MD-2 AND INTERLEUKIN-1β  Journal Article
• EVIDENCE THAT TRICYCLIC SMALL MOLECULES MAY POSSESS TOLL-LIKE RECEPTOR AND MYELOID DIFFERENTIATION PROTEIN 2 ACTIVITY  Journal Article
Evidence that opioids may have toll-like receptor 4 and MD-2 effects  Journal Article
Lovastatin inhibits Toll-like receptor 4 signaling in microglia by targeting its co-receptor myeloid differentiation protein 2 and attenuates neuropathic pain  Journal Article
Methamphetamine Activates Toll-Like Receptor 4 to Induce Central Immune Signaling within the Ventral Tegmental Area and Contributes to Extracellular Dopamine Increase in the Nucleus Accumbens Shell  Journal Article
Morphine activates neuroinflammation in a manner parallel to endotoxin  Journal Article
POSSIBLE INVOLVEMENT OF TOLL-LIKE RECEPTOR 4/MYELOID DIFFERENTIATION FACTOR-2 ACTIVITY OF OPIOID INACTIVE ISOMERS CAUSES SPINAL PROINFLAMMATION AND RELATED BEHAVIORAL CONSEQUENCES  Journal Article
Rifampin inhibits Toll-like receptor 4 signaling by targeting myeloid differentiation protein 2 and attenuates neuropathic pain  Journal Article
Stereochemistry and innate immune recognition: (+)-norbinaltorphimine targets myeloid differentiation protein 2 and inhibits toll-like receptor 4 signaling  Journal Article
... more

broader concept

• Carrier Proteins  PubMed MeSh Term